Literature DB >> 7286783

Nicotinic acid test in the diagnosis of Gilbert's syndrome: correlation with bilirubin clearance.

W Röllinghoff, G Paumgartner, R Preisig.   

Abstract

A provocation test with nicotinic acid (50 mg intravenously) was performed in 13 patients with Gilbert's syndrome and seven healthy volunteers to investigate the diagnostic value of several test parameters and to correlate them with the bilirubin clearance. The maximal increment of unconjugated serum bilirubin, the retention at four hours, and the area under the bilirubin concentration time curve. (AUC) were measured. Significant differences between patients and controls were found with regard to the AUC (7.95 +/- SD, 3.29 mmol/min/l vs. 3.08 +/- 0.57; P less than 0.001), the increment of unconjugated bilirubin (24.1 +/- 7.1 mumol/l vs. 10.2 +/- 3.2; P less than 0.001) and the retention (77.7 +/- 8.9% vs. 45.8 +/- 27.4%; P less than 0.02). Of those, the AUC discriminated best between patients and controls. Five patients with Gilbert's syndrome had normal serum bilirubin concentrations (less than 17.1 mumol/l = 1 mg%) at the time of the study, but abnormal AUC and bilirubin increment. A significant correlation was found between the bilirubin clearance and the retention (r = -0.96; P less than 0.001) as well as the AUC (r = -0.82; P less than 0.05) but not with the bilirubin increment. This simple test may be used to assess the disturbance of bilirubin clearance in Gilbert's syndrome.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7286783      PMCID: PMC1420060          DOI: 10.1136/gut.22.8.663

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  16 in total

1.  Reduced caloric intake and nicontinic acid provocation tests in the diagnosis of Gilbert's syndrome.

Authors:  A R Davidson; A Rojas-Bueno; R P Thompson; R Williams
Journal:  Br Med J       Date:  1975-05-31

2.  PLASMA BILIRUBIN DETERMINATION IN THE NEWBORN INFANT. A METHODOLOGICAL STUDY WITH SPECIAL REFERENCE TO THE INFLUENCE OF HEMOLYSIS.

Authors:  M MICHAUELSSON; B NOSSLIN; S SJOELIN
Journal:  Pediatrics       Date:  1965-06       Impact factor: 7.124

3.  [Proceedings: A simple method for the calculation of hepatic bilirubin clearance: its use in patients with Gilbert's syndrome].

Authors:  K Kutz; G Egger; H Bachofen; R Preisig
Journal:  Helv Med Acta       Date:  1974-05

4.  Criteria for assessment of functional impairment in patients with cirrhosis of the liver.

Authors:  J Bircher; R Blankart; A Halpern; W Häcki; J Laissue; R Preisig
Journal:  Eur J Clin Invest       Date:  1973-01       Impact factor: 4.686

5.  Hepatic bilirubin udp-glucuronyl transferase activity in liver disease and gilbert's syndrome.

Authors:  M Black; B H Billing
Journal:  N Engl J Med       Date:  1969-06-05       Impact factor: 91.245

6.  Determination of the hepatic elimination capacity (Lm) of galactose by single injection.

Authors:  N Tygstrup
Journal:  Scand J Clin Lab Invest Suppl       Date:  1966

7.  Changes in sulfobromophthalein transport and storage by the liver during viral hepatitis in man.

Authors:  R Preisig; R Williams; J Sweeting; S E Bradley
Journal:  Am J Med       Date:  1966-02       Impact factor: 4.965

8.  Aminopyrine demethylation measured by breath analysis in cirrhosis.

Authors:  J Bircher; A Küpfer; I Gikalov; R Preisig
Journal:  Clin Pharmacol Ther       Date:  1976-10       Impact factor: 6.875

9.  A new look at the plasma disappearance of sulfobromophthalein (BSP): correlation with the BSP transport maximum and the hepatic plasma flow in man.

Authors:  W Häcki; J Bircher; R Preisig
Journal:  J Lab Clin Med       Date:  1976-12

10.  Bilirubin turnover studies in normal and pathologic states using bilirubin-14C.

Authors:  V Barrett; P D Berk; M Menken; N I Berlin
Journal:  Ann Intern Med       Date:  1968-02       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.